A method and apparatus for in vivo molecular characterisation of human glioma
Patent Information
- Application Number
- GB2024015899
- Authority / Receiving Office
- GB · GB
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-10-29
- Publication Date
- 2026-11-11
Smart Images

Figure 00000000_0000_ABST
Abstract
Claims
1. An apparatus for in vivo profiling a region of biological tissue to determine its state of mutation, wherein the apparatus includes:a light source configured to generate at least one light beam;an optical arrangement configured to form the light beam into an optical probe beam for illuminating the region of biological tissue and receiving a Raman backscattered optical signal from the region of biological tissue, wherein the optical arrangement is further configured to filter the Raman backscattered optical signal to generate a filtered optical signal;an optical detector configured to receive the filtered optical signal to generate a corresponding detector signal including one or more components indicative of one or more molecular species present in the region of biological tissue; anda data processing arrangement configured to process the detector signal to determine from the one or more components a concentration of the one or more molecular species to compute the state of mutation of the biological tissue.
2. An apparatus of claim 1, wherein the apparatus is configured to measure whether or not the region of biological material includes at least one human glioma.
3. An apparatus of claim 1 or 2, wherein the apparatus is configured to compute the state of mutation in respect of a measurement of at least one of: an IDH mutation, an occurrence of ATRX loss, an occurrence of MGMT methylation.
4. An apparatus of claim 4, wherein the data processing arrangement is configured to detect the state of mutation as a function of the measurement exceeding a threshold, wherein the threshold is substantially 94%.
5. An apparatus of any one of the preceding claims, wherein the apparatus is configured to provide real-time in vivo computation of the state of mutation with a refresh time of less than 10 seconds, optionally less than 2 seconds.
6. An apparatus of any one of the preceding claims, wherein the apparatus is configured to compute the state of mutation from a Raman spectrum in a range of 300 to 2000 cm4.
7. An apparatus of any one of the preceding claims, wherein the apparatus is configured for at least one of the optical arrangement and one or more algorithms executed by the data processing arrangement to reduce an influence of extraneous ambient light radiation when computing the state of mutation.
8. An apparatus of claim 7, wherein the optical arrangement includes one or more optical filters for reducing the influence of extraneous ambient light radiation.
9. An apparatus of claim 7 or 8, wherein the apparatus is configured to process raw data of each Raman spectrum to apply thereto a background correction, a calibration and smoothing, a removal of autofluorescence, to generate corresponding filtered spectra for the data processing arrangement to process to compute the state of mutation.
10. An apparatus of any one of the preceding claims, wherein the data processing arrangement is configured to use a classification model using at least one of partial least squares computation and linear discriminant analysis (PLS-LDA) to compute the state of mutation y way of predicting genetic and epigenetic changes in the region of biological tissue.
11. An apparatus of any one of the preceding claims, wherein the optical arrangement is configured to include a flexible probe for a user of the apparatus to use to characterize the region of biological issue, wherein the flexible probe includes a flexible waveguide through which the optical probe beam is guided to the region of biological issue and though which the Raman backscattered optical signal obtained from the region of biological tissue is guided to be processed within the apparatus to compute the state of mutation of the biological tissue, wherein the flexible probed is optionally implemented as a flexible bifurcated optical fibre probe.
12. An apparatus of any one of the preceding claims, wherein the optical arrangement and the data processing arrangement are configured to measure amagnitude of at least one of following molecular species: glycogen and cholesterol, nucleic acids and amino acids, lipids (CH3) amides, amide 1.
13. An apparatus of any one of the preceding claims wherein the optical detector is implemented ss a CCD, and the light source is implemented as a wavelength-stabilized laser operating to provide substantially 785 nm wavelength output light.
14. Use of an apparatus of any one of the preceding claims for determining from the one or more components a concentration of the one or more molecular species to compute the state of mutation of the biological tissue.
15. A method for using an apparatus for in vivo profiling a region of biological tissue to determine its state of mutation, wherein the method includes:using a light source to generate a light beam;using an optical arrangement to form the light beam into an optical probe beam for illuminating the region of biological tissue and receiving a Raman backscattered optical signal from the region of biological tissue, wherein the optical arrangement is configured to filter the Raman backscattered optical signal to generate a filtered optical signal;using an optical detector to receive the filtered optical signal to generate a corresponding detector signal including one or more components indicative of one or more molecular species present in the region of biological tissue; andusing a data processing arrangement to process the detector signal to determine from the one or more components a concentration of the one or more molecular species to compute the state of mutation of the biological tissue.
16. A software product recorded on a machine-readable data storage medium, wherein the software product, when executed on computing hardware, is configured to execute a method of claim 15.28 01 26AMENDMENTS TO THE CLAIMS HAVE BEEN FILED AS FOLLOWS:-27CLAIMS1. An apparatus for in vivo profiling a region of biological tissue to determine its state of mutation, wherein the apparatus includes:a light source configured to generate at least one light beam;an optical arrangement configured to form the light beam into an optical probe beam for illuminating the region of biological tissue and receiving a Raman backscattered optical signal from the region of biological tissue, wherein the optical arrangement is further configured to filter the Raman backscattered optical signal to generate a filtered optical signal;an optical detector configured to receive the filtered optical signal to generate a corresponding detector signal including one or more components indicative of one or more molecular species present in the region of biological tissue; anda data processing arrangement configured to process the detector signal to determine from the one or more components a concentration of the one or more molecular species to compute the state of mutation of the biological tissue.
2. An apparatus of claim 1, wherein the apparatus is configured to measure whether or not the region of biological material includes at least one human glioma.
3. An apparatus of claim 1 or 2, wherein the apparatus is configured to compute the state of mutation in respect of a measurement of at least one of: an IDH mutation, an occurrence of ATRX loss, an occurrence of MGMT methylation.
4. An apparatus of claim 4, wherein the data processing arrangement is configured to detect the state of mutation as a function of the measurement exceeding a threshold, wherein the threshold is substantially 94%.
5. An apparatus of any one of the preceding claims, wherein the apparatus is configured to provide real-time in vivo computation of the state of mutation with a refresh time of less than 10 seconds, optionally less than 2 seconds.28 01 266. An apparatus of any one of the preceding claims, wherein the apparatus is configured to compute the state of mutation from a Raman spectrum in a range of 300 to 2000 cm'1.
7. An apparatus of any one of the preceding claims, wherein the apparatus is configured for at least one of the optical arrangement and one or more algorithms executed by the data processing arrangement to reduce an influence of extraneous ambient light radiation when computing the state of mutation.
8. An apparatus of claim 7, wherein the optical arrangement includes one or more optical filters for reducing the influence of extraneous ambient light radiation.
9. An apparatus of claim 7 or 8, wherein the apparatus is configured to process raw data of each Raman spectrum to apply thereto a background correction, a calibration and smoothing, a removal of autofluorescence, to generate corresponding filtered spectra for the data processing arrangement to process to compute the state of mutation.
10. An apparatus of any one of the preceding claims, wherein the data processing arrangement is configured to use a classification model using at least one of partial least squares computation and linear discriminant analysis (PLS-LDA) to compute the state of mutation y way of predicting genetic and epigenetic changes in the region of biological tissue.
11. An apparatus of any one of the preceding claims, wherein the optical arrangement is configured to include a flexible probe for a user of the apparatus to use to characterize the region of biological issue, wherein the flexible probe includes a flexible waveguide through which the optical probe beam is guided to the region of biological issue and though which the Raman backscattered optical signal obtained from the region of biological tissue is guided to be processed within the apparatus to compute the state of mutation of the biological tissue, wherein the flexible probed is optionally implemented as a flexible bifurcated optical fibre probe.
12. An apparatus of any one of the preceding claims, wherein the optical arrangement and the data processing arrangement are configured to measure a magnitude of at least one of following molecular species: glycogen and cholesterol, nucleic acids and amino acids, lipids (CH3) amides, amide 1.28 01 2613. An apparatus of any one of the preceding claims wherein the optical detector is implemented ss a CCD, and the light source is implemented as a wavelength-stabilized laser operating to provide substantially 785 nm wavelength output light.
14. Use of an apparatus of any one of the preceding claims for determining from the one or more components a concentration of the one or more molecular species to compute the state of mutation of the biological tissue.
15. A method for using an apparatus for in vivo profiling a region of biological tissue to determine its state of mutation, wherein the method includes:using a light source to generate a light beam;using an optical arrangement to form the light beam into an optical probe beam for illuminating the region of biological tissue and receiving a Raman backscattered optical signal from the region of biological tissue, wherein the optical arrangement is configured to filter the Raman backscattered optical signal to generate a filtered optical signal;using an optical detector to receive the filtered optical signal to generate a corresponding detector signal including one or more components indicative of one or more molecular species present in the region of biological tissue; andusing a data processing arrangement to process the detector signal to determine from the one or more components a concentration of the one or more molecular species to compute the state of mutation of the biological tissue.
16. A software product recorded on a machine-readable data storage medium, wherein the software product, when executed on computing hardware, is configured to execute a method of claim 15.A
